GlassScriptPhysician profile
Heidi Wilhelm Trehern
NPI 1326823899
$2,036.74
in general payments reported to CMS, 2019-2025
17 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $35.83 · 2024: $854 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,036.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $512.44 | 2024-2025 | |
| Abbvie INC. | $478.27 | 2023-2025 | |
| Novo Nordisk INC | $317.54 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $123.01 | 2024-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $100.35 | 2024-2025 | Rexulti, Abilify Maintena |
| Shield Therapeutics INC | $78.91 | 2024-2025 | |
| Lilly USA, LLC | $78.11 | 2024-2025 | Zepbound, Mounjaro |
| Amgen INC. | $73.18 | 2023-2025 | Tepezza, Repatha, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $62.45 | 2024-2025 | Trintellix |
| Novartis Pharmaceuticals Corporation | $45.91 | 2024 | |
| Glaxosmithkline, LLC. | $44.17 | 2024-2025 | Trelegy Ellipta |
| Dexcom, INC. | $43.80 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Axsome Therapeutics, INC. | $21.42 | 2025 | Symbravo |
| Exact Sciences Corporation | $15.66 | 2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $14.45 | 2024 | Breztri |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $13.59 | 2025 | Jornay Pm |
| Lundbeck LLC | $13.48 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Trehern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.